Becton, Dickinson and Co. | BDX - Debt


Becton, Dickinson and Co. reported $17.28B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.35B 0 Dec/2025
Align Technology USD 116.04M 1.6M Mar/2026
AngioDynamics USD 6.3M 6.3M Feb/2025
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Bio-Rad Laboratories USD 1.38B 7.9M Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
Cooper Companies USD 2.5B 5.6M Dec/2025
Danaher USD 26.56B 8.07B Jun/2026
Dentsply International USD 2.33B 137M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Globus Medical USD 115.22M 3.43M Mar/2026
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Medtronic USD 28.07B 1.03B Dec/2025
Solventum Corp USD 7.91B 97M Mar/2025
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 734.74M 290.26M Mar/2026
Teleflex USD 2.69B 39.95M Mar/2026
Terumo JPY 159.87B 14.97B Sep/2025
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026